Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes

2019 ◽  
Vol 37 (4) ◽  
pp. 805-813 ◽  
Author(s):  
Francesca Viazzi ◽  
Barbara Bonino ◽  
Antonio Mirijello ◽  
Paola Fioretto ◽  
Carlo Giorda ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Blood Pressure Variability

scholarly journals The influence of long‐term administration of SGLT2 inhibitors on blood pressure at the office and at home in patients with type 2 diabetes mellitus and chronic kidney disease

2020 ◽  
Vol 22 (12) ◽  
pp. 2306-2314
Author(s):  
Takayuki Furuki ◽  
Kazuo Kobayashi ◽  
Masao Toyoda ◽  
Nobuo Hatori ◽  
Hiroyuki Sakai ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Type 2 Diabetes Mellitus ◽  
Kidney Disease ◽  
Sglt2 Inhibitors ◽  
Term Administration

scholarly journals The Peculiarity of Process and Treatment of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus

2020 ◽  
Vol 16 (4) ◽  
pp. 623-634
Author(s):  
T. Yu. Demidova ◽  
O. A. Kislyak
Keyword(s):  
Diabetes Mellitus ◽  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Type 2 Diabetes Mellitus ◽  
Kidney Disease ◽  
Arterial Hypertension ◽  
Pathogenic Mechanisms

Arterial hypertension (AH) is powerful and modifying factor of developing macrovascular and microvascular complications of diabetes. Patients with AH and diabetes belong to group with high and very high levels risk of developing cardiovascular complications and chronic kidney disease. The combination of type 2 diabetes mellitus and AH dramatically increases the risk of developing terminal stages of microvascular and macrovascular diabetic complications: blindness, end-stage chronic kidney disease, amputation of the lower extremities, myocardial infarction, cerebral stroke, worsens the patients prognosis and quality of life. There is ample evidence that blood pressure control in diabetic patients may be critical for improving long-term prognosis. This observation does not lose its relevance even with the emergence of new antidiabetic drugs with proven cardio- and nephroprotective effects. Modern clinical researchers and meta-analysis show the priority of combined antihypertensive therapy, which increases the efficacy of blood pressure correction and prophylaxis of long-term complications in patients with type 2 diabetes. In this article we want to pay attention to features of AH in patients with diabetes, to bi-directional pathogenic mechanisms, to discuss the new algorithms of the treatment and therapeutic needs of these patients. It is important to accent the understanding of the integrity and unity of pathogenic mechanisms which are needed in correction. Innovative antihyperglycemic therapy demonstrates the ability of blood pressure decrease. The synergy of effects let us successfully realize the strategy of multi-factor control and reduce a risk of micro- and macrovascular complications.

PS 17-51 VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY AND CHRONIC KIDNEY DISEASE IN TYPE 2 DIABETES PATIENTS IN GHANA

2016 ◽  
Vol 34 (Supplement 1) ◽  
pp. e488
Author(s):  
Kwame Yeboah ◽  
Ernest Yorke ◽  
Kennedy Konlan
Keyword(s):  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Blood Pressure Variability ◽  
Diabetes Patients

Long-term blood pressure variability, incidence of hypertension and changes in renal function in type 2 diabetes

2020 ◽  
Vol 38 (11) ◽  
pp. 2279-2286
Author(s):  
Francesca Viazzi ◽  
Elisa Russo ◽  
Antonio Mirijello ◽  
Paola Fioretto ◽  
Carlo Giorda ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Renal Function ◽  
Blood Pressure Variability

scholarly journals Long-term quality-of-care score predicts incident chronic kidney disease in patients with type 2 diabetes

2018 ◽  
Vol 33 (11) ◽  
pp. 2012-2019 ◽  
Author(s):  
Pi-I Li ◽  
Jian-Nan Wang ◽  
How-Ran Guo
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Quality Of Care ◽  
Kidney Disease ◽  
Incident Chronic Kidney Disease

Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes

2017 ◽  
Vol 19 (11) ◽  
pp. 1570-1578 ◽  
Author(s):  
Antonio Ceriello ◽  
Salvatore De Cosmo ◽  
Maria Chiara Rossi ◽  
Giuseppe Lucisano ◽  
Stefano Genovese ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Uric Acid ◽  
Kidney Disease ◽  
Serum Uric Acid ◽  
Lipid Parameters

scholarly journals Long-Term Blood Pressure Variability, New-Onset Diabetes Mellitus, and New-Onset Chronic Kidney Disease in the Japanese General Population

Hypertension ◽  
2015 ◽  
Vol 66 (1) ◽  
pp. 30-36 ◽  
Author(s):  
Yuichiro Yano ◽  
Shouichi Fujimoto ◽  
Holly Kramer ◽  
Yuji Sato ◽  
Tsuneo Konta ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Blood Pressure ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
General Population ◽  
Blood Pressure Variability ◽  
Japanese General Population ◽  
New Onset Diabetes Mellitus ◽  
New Onset

[OP.2B.05] LONG TERM, BUT NOT SHORT TERM, BLOOD PRESSURE VARIABILITY PREDICTS CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS

2016 ◽  
Vol 34 ◽  
pp. e20
Author(s):  
F. Mallamaci ◽  
R. Minutolo ◽  
G. Stanzione ◽  
G. D’Arrigo ◽  
D. Leonardis ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Blood Pressure Variability ◽  
Cardiovascular Outcomes ◽  
Short Term

scholarly journals Individual Atrasentan Exposure is Associated With Long‐term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease

2021 ◽  
Author(s):  
Jeroen V. Koomen ◽  
Jasper Stevens ◽  
George Bakris ◽  
Ricardo Correa‐Rotter ◽  
Fan Fan Hou ◽  
...  
Keyword(s):  
Heart Failure ◽  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Kidney Disease
Sign in / Sign up

Export Citation Format

Share Document